Journal Article

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates

Author(s)

Payton A. -B. Weidenbacher/Stanford University
Mrinmoy Sanyal/Stanford University; Stanford University School of Medicine
Natalia Friedland/Stanford University; Stanford University School of Medicine
Shaogeng Tang/Stanford University; Stanford University School of Medicine
Prabhu S Arunachalam/Stanford University School of Medicine
Mengyun Hu/Stanford University School of Medicine
Ozan S Kumru/University of Kansas
Mary Kate Morris/California Department of Public Health
Jane Fontenot/University of Louisiana at Lafayette
Lisa Shirreff/University of Louisiana at Lafayette
Jonathan Do/Stanford University; Stanford University School of Medicine
Ya-Chen Cheng/Stanford University; Stanford University School of Medicine
Gayathri Vasudevan/IAVI
Mark B Feinberg/IAVI
Francois J Villinger/University of Louisiana at Lafayette
Carl Hanson/California Department of Public Health
Sangeeta B Joshi/University of Kansas
David B Volkin/University of Kansas
Bali Pulendran/Stanford University; Stanford University School of Medicine
Peter S Kim/Stanford University; Stanford University School of Medicine

Publisher

Nature Comminucations

Publication Date

April 17, 2023

DOI

https://doi.org/10.1038/s41467-023037417-9

© 2026 SLAC National Accelerator Laboratory is operated by Stanford University for the U.S. Department of Energy Office of Science.